CDMO Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PARDAVIMAS 114095 min ago

@ $6.64

Išleistas: 13 vas. 2024 @ 22:43

Grąža: 23.49%

Ankstesnis signalas: vas. 13 - 16:30

Ankstesnis signalas: Pirkimas

Grąža: -1.48 %

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 23:00):

Stats
Šios dienos apimtis	1.81M
Vidutinė apimtis	1.37M
Rinkos kapitalizacija	520.53M
EPS	$0 ( 2024-04-29 )
Kita pelno data	( $0 ) 2024-06-19
Last Dividend	$0.656 ( 2018-03-16 )
Next Dividend	$0 ( N/A )
P/E	-29.29
ATR14	$0.0160 (0.20%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-30	Ziebell Mark R	Sell	1 643	Common Stock, $0.001 par value
2024-04-30	Richieri Richard A.	Sell	1 005	Common Stock, $0.001 par value
2024-04-30	Richieri Richard A.	Sell	109	Common Stock, $0.001 par value
2024-04-30	Kwietniak Matthew R.	Sell	1 233	Common Stock, $0.001 par value
2024-04-30	Hart Daniel R	Sell	2 826	Common Stock, $0.001 par value

INSIDER POWER
29.14
Last 100 transactions
Buy: 250 957 \| Sell: 129 263

Tūris Koreliacija

Ilgas: -0.09 (neutral)

Trumpas: 0.76 (moderate)

Signal:(54.073) Neutral

Avid Bioservices Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
EMLD	0.912
ARRW	0.911
FEXD	0.891
ESCA	0.891
CPAQ	0.89
FTAA	0.889
TWLV	0.888
ARDX	0.888
ABGI	0.884
NBST	0.883

10 Labiausiai neigiamai susiję koreliacijos
CUTR	-0.894
PEAR	-0.892
GRIN	-0.892
HRMY	-0.891
GCBC	-0.891
ORPH	-0.89
SRCE	-0.888
GSBC	-0.886
FCBC	-0.882
VORB	-0.879

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Avid Bioservices Inc Koreliacija - Valiuta/Žaliavos

0.28
( neutral )

0.05
( neutral )

0.00
( neutral )

-0.04
( neutral )

0.50
( neutral )

-0.15
( neutral )

Avid Bioservices Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$149.27M
Bruto pelnas:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2023
Pajamos:	$149.27M
Bruto pelnas:	$31.48M (21.09 %)
EPS:	$0.00900

FY	2022
Pajamos:	$119.60M
Bruto pelnas:	$36.65M (30.64 %)
EPS:	$2.08

FY	2021
Pajamos:	$95.87M
Bruto pelnas:	$29.31M (30.57 %)
EPS:	$0.0600

Financial Reports:

No articles found.

Avid Bioservices Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Avid Bioservices Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0722 - No dividend growth expected in the near future

Information

First Dividend	$0.656	2018-03-16
Last Dividend	$0.656	2018-03-16
Next Dividend	$0	N/A
Payout Date	2018-04-02
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$0.656	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0722
Div. Directional Score	0	--

Next Divdend (Est)
(2024-05-03)

$0 Estimate 0.00 %

Dividend Stability

0.01 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2018	$0.656	16.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.131	1.500	-2.62	-3.93	[0 - 0.5]
returnOnAssetsTTM	-0.0394	1.200	-1.312	-1.574	[0 - 0.3]
returnOnEquityTTM	-0.0963	1.500	-2.18	-3.27	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.465	0.800	-2.68	-2.14	[1 - 3]
quickRatioTTM	0.297	0.800	-2.96	-2.37	[0.8 - 2.5]
cashRatioTTM	0.138	1.500	-0.346	-0.519	[0.2 - 2]
debtRatioTTM	0.431	-1.500	2.81	-4.22	[0 - 0.6]
interestCoverageTTM	-10.85	1.000	-5.13	-5.13	[3 - 30]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
freeCashFlowPerShareTTM	-0.608	2.00	-0.304	-0.608	[0 - 20]
debtEquityRatioTTM	1.090	-1.500	5.64	-8.46	[0 - 2.5]
grossProfitMarginTTM	0.0747	1.000	-2.09	-2.09	[0.2 - 0.8]
operatingProfitMarginTTM	-0.132	1.000	-4.64	-4.64	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0627	1.000	-0.763	-0.763	[0.2 - 2]
assetTurnoverTTM	0.300	0.800	-1.331	-1.065	[0.5 - 2]
Total Score				-0.942

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-27.11	1.000	-2.84	0	[1 - 100]
returnOnEquityTTM	-0.0963	2.50	-1.402	-3.27	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.608	2.00	-0.203	-0.608	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.194	2.00	9.94	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.272	1.500	-1.518	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0900	1.000	-0.250	0	[0.1 - 0.5]
Total Score				0.0722

Avid Bioservices Inc

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.